Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group
Status:
Completed
Trial end date:
2001-10-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to
assess the effect of NNC 90-1170 on beta-cell responsiveness to increasing blood glucose
concentrations in subjects with type 2 diabetes.